Gossamer Bio Inc (GOSS)
0.38
-8.50%
Gossamer Bio Inc (GOSS) is currently trading at $0.38. This represents a loss of 8.5% from the previous session. With a market capitalization of $0.09B, GOSS is a key component of the Health Care sector. Investors looking to trade GOSS should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade GOSS commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Gossamer Bio Inc (GOSS) shows a bearish trend. Analysts are watching the 0.40 level closely.
Fundamentals
Mkt Cap0.09B
P/E Ratio0.0000
Volume0
60-Day Technical Chart
Advanced Charting
Need more indicators for GOSS? Use the world's #1 platform.
Open GOSS on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $0
| Metric |
GOSS -8.50% |
OPTT -2.10% |
|---|---|---|
| Price | $0.38 | $0.41 |
| Mkt Cap | $0.09B | $0.08B |
| - | View → |
Latest Headlines
Gossamer Bio shares plummet as lung disease drug fails late-stage trial
Reuters • Feb 23, 2026
Gossamer Bio Announces Topline Results from the Phase 3 PROSERA Study Evaluating Seralutinib in Pulmonary Arterial Hypertension
Business Wire • Feb 23, 2026
Gossamer Bio stock tumbles 80% on trial miss
Investing.com • Feb 23, 2026
Gossamer Bio Stock Plummeted 82% Today — What’s Behind The Crash?
Stocktwits • Feb 23, 2026
BREAKING: Gossamer Bio Investors Should Contact Block &
GlobeNewswire • Feb 23, 2026
● Gemini Agentic AI Analyst Insight for GOSS
Market Education
- I am a newbie Trader, how do I start trading Jul 15, 2023
- Tax Loss Selling: A Strategic Way to Offset Gains Dec 10, 2024
- Stock Valuation Dec 16, 2023
External Research